The antidepressant fluvoxamine may prevent hospitalization and death in patients with COVID-19, new research suggests.
David Boulware, MD, MPH, an infectious disease doctor-researcher at the University of Minnesota, said fluvoxamine is"a $10 medicine that's available and has a very good safety record."accompanying editorial
, Otavio Berwanger, cardiologist and researcher, from the Hospital Israelita Albert Einstein in Sao Paulo, Brazil, commends the investigators for rapidly generating evidence during the COVID-19 pandemic. However, despite the important findings,"some questions related to efficacy and safety of fluvoxamine for patients with COVID-19 remain open," Berwanger writes.For example, he said, it is unclear if fluvoxamine adds to other existing treatments.
"I believe medical and scientific societies will need to critically appraise the manuscript in order to inform their decisions and recommendations. This interesting trial adds another important piece of information in this regard," he said.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Cheap, generic antidepressant shows promise in treating early COVID-19A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing drugs that could be...
続きを読む »
Antidepressant Significantly Reduces Covid-19 HospitalizationCovid-19 patients who were given the low-cost antidepressant fluvoxamine were significantly less likely to require hospitalization compared with those who weren’t, according to a new study
続きを読む »
Cheap antidepressant shows promise treating early COVID-19A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing drugs that could be repurposed to treat coronavirus.
続きを読む »
Immunocompromised may need a fourth Covid-19 shot, CDC saysPeople with certain health conditions that make them moderately or severely immunocompromised may get a fourth mRNA Covid-19 shot, according to updated guidelines from the CDC
続きを読む »
Cheap, generic anti-depressant may reduce severe Covid-19 disease, study findsA cheap, generically available anti-depressant may reduce the risk of severe Covid-19 disease by close to a third in people at high risk, researchers reported Wednesday.
続きを読む »
Study Finds Fluvoxamine — A $4 Antidepressant — May Cut Covid Hospitalization RiskResearchers hailed fluvoxamine — which is normally used to treat obsessive-compulsive disorder — for its “safety, tolerability, ease of use, low cost, and widespread availability.”
続きを読む »